Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection

Vaccine

Volumn 23, Issue 34, 2005, Pages 4342-4352

  González, Belén ^a,b   Reina, Ramsés ^a,b   García, Iker ^a,b   Andrés, Sara ^a,b   Glaria, Idoia ^a,b   Alzueta, María ^a,b   Mora, María Isabel ^a,b   Jugo, Begoña M ^c   Arrieta Aguirre, Inés ^c   Pérez De La Lastra, José M ^a,b   Rodríguez, Dolores ^d   Rodríguez, Juan Ramón ^d,j   Esteban, Mariano ^d   Grilló, María Jesús ^a,b   Blacklaws, Barbara A ^e   Harkiss, Gordon D ^f   Chebloune, Yahia ^g,h   Luján, Lluís ⁱ   De Andrés, Damián ^a,b   Amorena, Beatriz ^a,b  

^a Instituto Agroalimentario de Aragón IA2   (Spain)

^b CSIC   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITÉ LYON 1   (France)

^h UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF ZARAGOZA   (Spain)

^j Bionostra   (Spain)

more..

Author keywords

DNA vaccine; Gene gun; Maedi Visna

Indexed keywords

BETA GALACTOSIDASE; DNA VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT GAMMA INTERFERON; VIRUS VACCINE;

ALLELE; ARTICLE; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; GENE EXPRESSION; GENE GUN; GENE SEQUENCE; GENOTYPE; HERD; HETEROZYGOSITY; IMMUNIZATION; INFECTION RESISTANCE; MUCOSAL IMMUNITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTECTION; PROVOCATION TEST; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VISNA VIRUS;

ANIMALS; BIOLISTICS; FEMALE; GENE PRODUCTS, ENV; GENES, MHC CLASS II; HLA-DR ANTIGENS; IMMUNITY, MUCOSAL; IMMUNIZATION; INTERFERON TYPE II; PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP; SHEEP; VACCINES, DNA; VIRAL LOAD; VIRAL VACCINES; VISNA; VISNA-MAEDI VIRUS;

EID: 22244439827     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.03.032     Document Type: Article

References (72)

1. M.J. Burkhard, L. Valenski, S. Leavell, G.A. Dean, and W.A. Tompkins Evaluation of FIV protein-expressing VEE-replicon vaccine vectors in cats Vaccine 21 3-4 2002 258 268
2. S.P. Dunham, J.N. Flynn, M.A. Rigby, J. Macdonald, J. Bruce, and C. Cannon Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18 Vaccine 20 11-12 2002 1483 1496
3. T.U. Vogel, M.R. Reynolds, D.H. Fuller, K. Vielhuber, T. Shipley, and J.T. Fuller Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239 J Virol 77 24 2003 13348 13360
4. Z. Bu, L. Ye, R.W. Compans, and C. Yang Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins Virology 309 2 2003 272 281
5. P. Spearman HIV vaccine development: lessons from the past and promise for the future Curr HIV Res 1 1 2003 101 120
6. J.F. Bower, X. Yang, J. Sodroski, and T.M. Ross Elicitation of neutralizing antibodies with DNA Vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d J Virol 78 9 2004 4710 4719
7. J. Gzyl, E. Bolesta, A. Wierzbicki, D. Kmieciak, T. Naito, and M. Honda Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses Virology 318 2 2004 493 506
8. M. Giri, K.E. Ugen, and D.B. Weiner DNA vaccines against human immunodeficiency virus type 1 in the past decade Clin Microbiol Rev 17 2 2004 370 389
9. A. Harmache, C. Vitu, F. Guiguen, P. Russo, G. Bertoni, and M. Pépin Priming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV J Virol 72 8 1998 6796 6804
10. J.C. Beyer, R.W. Stich, D.S. Hoover, W.C. Brown, and W.P. Cheevers Cloning and expression of caprine interferon-gamma Gene 210 1 1998 103 108
11. J.C. Beyer, Y. Chebloune, L. Mselli-Lakhal, I. Hotzel, N. Kumpula-McWhirter, and W.P. Cheevers Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein Vaccine 19 13-14 2001 1643 1651
12. W.P. Cheevers, J.C. Beyer, and I. Hotzel Plasmid DNA encoding caprine interferon gamma inhibits antibody response to caprine arthritis-encephalitis virus (CAEV) surface protein encoded by a co-administered plasmid expressing CAEV env and tat genes Vaccine 19 23-24 2001 3209 3215
13. W.P. Cheevers, K.R. Snekvik, J.D. Trujillo, N.M. Kumpula-McWhirter, K.J. Pretty On Top, and D.P. Knowles Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis Virology 306 1 2003 116 125
14. R.C. Cutlip, H.D. Lehmkuhl, K.A. Brogden, and M.J. Schmerr Failure of experimental vaccines to protect against infection with ovine progressive pneumonia (Maedi-Visna) virus Vet Microbiol 13 3 1987 201 204
15. M. Gudnadottir Experiments with inactivated visna-maedi vaccine Ann NY Acad Sci 724 1994 140 147
16. P. Bird, H.T. Reyburn, B.A. Blacklaws, D. Allen, P. Nettleton, and D.L. Yirrell The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein Clin Exp Immunol 102 2 1995 274 280
17. D.L. Huso Neutralizing and fusion-blocking antibodies induced by recombinant visna virus envelope glycoprotein Viral Immunol 10 1 1997 15 20
18. J.E. Keen, L.L. Hungerford, E.T. Littledike, T.E. Wittum, and J. Kwang Effect of Ewe ovine lentivirus infection on Ewe and lamb productivity Prev Vet Med 30 2 1997 155 169
19. B. Rafnar, G.J. Tobin, K. Nagashima, M.A. Gonda, E. Gunnarsson, and O.S. Andresson Immune response to recombinant visna virus Gag and Env precursor proteins synthesized in insect cells Virus Res 53 2 1998 107 120
20. M.M. Garcia-Briones, G.C. Russell, R.A. Oliver, C. Tami, O. Taboga, and E. Carrillo Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge Vaccine 19 9-10 2001 1167 1171
21. I. Ourmanov, C.R. Brown, B. Moss, M. Carroll, L. Wyatt, and L. Pletneva Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV J Virol 74 6 2000 2740 2751
22. I.M. Belyakov, S.A. Hammond, J.D. Ahlers, G.M. Glenn, and J.A. Berzofsky Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells J Clin Invest 113 7 2004 998 1007
23. L. Stevceva, and W. Strober Mucosal HIV vaccines: where are we now? Curr HIV Res 2 1 2004 1 10
24. B.I. Loehr, P. Willson, L.A. Babiuk, and H. van Drunen Littel-van den Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpesvirus 1 in cattle J Virol 74 13 2000 6077 6086
25. A. Fomsgaard, H.V. Nielsen, N. Kirkby, K. Bryder, S. Corbet, and C. Nielsen Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes Vaccine 18 7-8 1999 681 691
26. D.H. Barouch, S. Santra, T.D. Steenbeke, X.X. Zheng, H.C. Perry, and M.E. Davies Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration J Immunol 161 4 1998 1875 1882
27. J. Thalhamer, W. Leitner, P. Hammerl, and J. Brtko Designing immune responses with genetic immunization and immunostimulatory DNA sequences Endocr Regul 35 3 2001 143 166
28. P. Bird, B. Blacklaws, H.T. Reyburn, D. Allen, J. Hopkins, and D. Sargan Early events in immune evasion by the lentivirus Maedi-Visna occurring within infected lymphoid tissue J Virol 67 9 1993 5187 5197
29. V. Andresdottir, R. Skraban, S. Matthiasdottir, R. Lutley, G. Agnarsdottir, and H. Thorsteinsdottir Selection of antigenic variants in Maedi-Visna virus infection J Gen Virol 83 Pt. 10 2002 2543 2551
30. A.M. Cuisinier, V. Mallet, A. Meyer, C. Caldora, and A. Aubert DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus Vaccine 15 10 1997 1085 1094
31. G. Ruff, and S. Lazary Evidence for linkage between the caprine leucocyte antigen (CLA) system and susceptibility to CAE virus-induced arthritis in goats Immunogenetics 28 5 1988 303 309
32. G. Ruff, J.G. Regli, and S. Lazary Occurrence of caprine leucocyte class I and II antigens in Saanen goats affected by caprine arthritis (CAE) Eur J Immunogenet 20 4 1993 285 288
33. F.-W. Schwaiger, J. Maddox, K. Ballingall, J. Buitkamp, A.M. Crawford, and B.M. Dutia L.B.S.S.J. Lamont The ovine major histocompatibility complex. The major histocompatibility complex region of domestic animal species 1996 CRC Press Boca Raton, FL 121 176
34. B.M. Jugo, and A. Vicario Single-strand conformational polymorphism and sequence polymorphism of Mhc-DRB in Latxa and Karrantzar sheep: implications for Caprinae phylogeny Immunogenetics 51 11 2000 887 897
35. S. Konnai, Y. Nagaoka, S. Takeshima, M. Onuma, and Y. Aida Sequences and diversity of 17 new Ovar-DRB1 alleles from three breeds of sheep Eur J Immunogenet 30 4 2003 275 282
36. B. González, L. Luján, S. Andrés, R. Reina, D. de Andrés, and A. Vargas Desarrollo metodológico para la utilización de la pistola de genes en la inmunización frente al virus Maedi Visna en ovinos Rasa Aragonesa Inf Téc Econ Agrar 22 I 2001 191 193
37. D.R. Sargan, I.D. Bennet, C. Cousens, D.J. Roy, B.A. Blacklaws, and R.G. Dalziel Nucleotide sequence of EV1, a British isolate of Maedi-Visna virus J Gen Virol 72 Pt. 8 1991 1893 1903
38. B. González, L. Luján, C. Pacheco, S. Andrés, R. Reina, and D. de Andrés Comparación de distintas estrategias de inoculación y dosis vírica necesaria para provocar la infección por Maedi-Visna en ovinos Inf Téc Econ Agrar 22 I 2001 194 196
39. L.J. Reed, and H. Muench A simple method of estimating fifty per cent endpoints Am. J. Hygiene 27 1938 493 497
40. F. Tolari, C. Cosi, M.L. Carrozza, M. Mazzei, and P. Bandecchi Comparison of ELISA, Immunoblotting and PCR to detect MVV infected sheep Proceedings of the International Conference Animal Retroviruses, vol. 1, Queen's College, Cambridge, UK 2000 61
41. M. Orita, Y. Suzuki, T. Sekiya, and K. Hayashi Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction Genomics 5 4 1989 874 879
42. M.K. Baum Role of micronutrients in HIV-infected intravenous drug users J Acquir Immune Defic Syndr 25 Suppl. 1 2000 49 52
43. M.A. Beck, and O.A. Levander Host nutritional status and its effect on a viral pathogen J Infect Dis 182 Suppl. 1 2000 93 96
44. E.W. Taylor, A.G. Cox, L. Zhao, J.A. Ruzicka, A.A. Bhat, and W. Zhang Nutrition, HIV, and drug abuse: the molecular basis of a unique role for selenium J Acquir Immune Defic Syndr 25 Suppl. 1 2000 53 61
45. L. Bruett, S.A. Barber, and J.E. Clements Characterization of a membrane-associated protein implicated in visna virus binding and infection Virology 271 1 2000 132 141
46. J.W. Lyall, N. Solanky, and L.S. Tiley Restricted species tropism of Maedi-Visna virus strain EV-1 is not due to limited receptor distribution J Gen Virol 81 Pt. 12 2000 2919 2927
47. D.G. Fraser, R.H. Mealey, and T.C. McGuire Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides Immunogenetics 55 7 2003 508 514
48. P. Mooij, I.G. Nieuwenhuis, C.J. Knoop, R.W. Doms, W.M. Bogers, and P.J. Ten Haaft Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection J Virol 78 7 2004 3333 3342
49. T. Zhu, L. Corey, Y. Hwangbo, J.M. Lee, G.H. Learn, and J.I. Mullins Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals J Virol 77 11 2003 6108 6116
50. W.P. Cheevers, T.C. McGuire, L.K. Norton, R. Cordery-Cotter, and D.P. Knowles Failure of neutralizing antibody to regulate CAE lentivirus expression in vivo Virology 196 2 1993 835 839
51. R.K. Kemp, D.P. Knowles, L.L. Perry, T.C. McGuire, T.E. Besser, and W.P. Cheevers Crossreactive neutralizing antibodies induced by immunization with caprine arthritis-encephalitis virus surface glycoprotein Vaccine 18 13 2000 1282 1287
52. H. Horton, T.U. Vogel, D.K. Carter, K. Vielhuber, D.H. Fuller, and T. Shipley Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239 J Virol 76 14 2002 7187 7202
53. J.E. Schmitz, M.J. Kuroda, S. Santra, M.A. Simon, M.A. Lifton, and W. Lin Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virus J Virol 77 3 2003 2165 2173
54. E. Saman, G. Van Eynde, L. Lujan, B. Extramiana, G. Harkiss, and F. Tolari A new sensitive serological assay for detection of lentivirus infections in small ruminants Clin Diagn Lab Immunol 6 5 1999 734 740
55. R. Varea, E. Monleon, C. Pacheco, L. Lujan, R. Bolea, and M.A. Vargas Early detection of Maedi-Visna (ovine progressive pneumonia) virus seroconversion in field sheep samples J Vet Diagn Invest 13 4 2001 301 307
56. T. Morin, F. Guiguen, B.A. Bouzar, S. Villet, T. Greenland, and D. Grezel Clearance of a productive lentivirus infection in calves experimentally inoculated with caprine arthritis-encephalitis virus J Virol 77 11 2003 6430 6437
57. J.A. Karlas, K.H. Siebelink, M.A. v Peer, W. Huisman, G.F. Rimmelzwaan, and A.D. Osterhaus Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells Vet Immunol Immunopathol 65 2-4 1998 353 365
58. H.C. Chang, T.L. Lin, and C.C. Wu DNA vaccination with plasmids containing various fragments of large segment genome of infectious bursal disease virus Vaccine 21 5-6 2003 507 513
59. A. Tanghe, O. Denis, B. Lambrecht, V. Motte, T. van den Berg, and K. Huygen Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment Infect Immun 68 7 2000 3854 3860
60. M. Giese DNA-antiviral vaccines: new developments and approaches - a review Virus Genes 17 3 1998 219 232
61. M.C. Rebelatto, L. Siger, and H. Hogenesch Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves Res Vet Sci 71 1 2001 9 15
62. I. Nobiron, I. Thompson, J. Brownlie, and M.E. Collins DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge Vaccine 21 17-18 2003 2082 2092
63. J. Wang, T. Murakami, S. Yoshida, H. Matsuoka, A. Ishii, and T. Tanaka Predominant cell-mediated immunity in the oral mucosa: gene gun-based vaccination against infectious diseases J Dermatol Sci 31 3 2003 203 210
64. C. Buckner, L.G. Gines, C.J. Saunders, L. Vojtech, I. Srivastava, and A. Gettie Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV Virology 320 1 2004 167 180
65. D.R. Casimiro, A. Tang, L. Chen, T.M. Fu, R.K. Evans, and M.E. Davies Vaccine-induced immunity in baboons by using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene J Virol 77 13 2003 7663 7668
66. H. Loessner, and S. Weiss Bacteria-mediated DNA transfer in gene therapy and vaccination Expert Opin Biol Ther 4 2 2004 157 168
67. R.S. Chu, O.S. Targoni, A.M. Krieg, P.V. Lehmann, and C.V. Harding CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity J Exp Med 186 10 1997 1623 1631
68. W.P. Cheevers, I. Hotzel, J.C. Beyer, and N. Kumpula-McWhirter Immune response to caprine arthritis-encephalitis virus surface protein induced by coimmunization with recombinant vaccinia viruses expressing the caprine arthritis-encephalitis virus envelope gene and caprine interleukin-12 Vaccine 18 23 2000 2494 2503
69. F.M. Bertley, P.A. Kozlowski, S.W. Wang, J. Chappelle, J. Patel, and O. Sonuyi Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates J Immunol 172 6 2004 3745 3757
70. P.J. Lewis, G.J.M. Cox, S. van Drunen Littel-van den Hurk, and L.A. Babiuk Polynucleotide vaccines in animals: enhancing and modulating responses Vaccine 15 8 1997 861 864
71. A.D. Cohen, J.D. Boyer, and D.B. Weiner Modulating the immune response to genetic immunization FASEB J 12 15 1998 1611 1626
72. S. Mikko, K. Roed, S. Schmutz, and L. Andersson Monomorphism and polymorphism at MHC DRB loci in domestic and wild ruminants Immunol Rev 167 1999 169 178